This potential TGF-β–FOXL1–Grem1/Islr axis that modulates BMP signaling in the colon provides a novel mechanism, to our knowledge, to help understand the polarization of CAFs within the tumor microenvironment and presents a promising target for future cancer treatment. This evidence concerns the gene GREM1 and neoplasm.